Cannabis stocks rallied for a second day Wednesday, buoyed by a historic congressional committee passage of a bill that aims to lift the federal ban on weed, as well as strong gains for Curaleaf after it posted a narrower-than-expected third-quarter loss.
Analysts polled by FactSet had expected losses of 2 cents a share on revenue of $63.6 million.
Cannabis stocks are still going through a period of retrenchment after a deep slump in stock prices.
The Horizons Marijuana Life Sciences ETF CA:HMMJ was up 6.5%, with 42 of its 54 member stocks higher.
Cannabis Watch: Click here for all of MarketWatchâ€™s coverage of cannabis companies